GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

Professor Sarah Blagden, from the University of Oxford, will co-lead the new GSK-Oxford Cancer Immuno-Prevention Programme, which is backed by £50 million from GSK. She told BBC Radio 4’s Today ...